Displayed in 1999 as a work-in-progress, Shimadzu's SDU-2200 will be shown as a finished product at this year's RSNA meeting. A new version of the SDU-450, the SDU-450 XL, will also be introduced.The SDU-2200 system includes 3-D, tissue harmonic imaging,
Displayed in 1999 as a work-in-progress, Shimadzu's SDU-2200 will be shown as a finished product at this year's RSNA meeting. A new version of the SDU-450, the SDU-450 XL, will also be introduced.
The SDU-2200 system includes 3-D, tissue harmonic imaging, and DICOM connectivity. Its proprietary digital electronics provide high-speed parallel processing, a quad digital beamformer, and high-level digital noise suppression. The SDU-2200 is a multipurpose, shared services system with applications that include cardiac, vascular, abdominal, ob/gyn, and urology.
The SDU-1200 uses the same console, operating system, and digital electronics as the SDU-2200. Applications are vascular, abdominal, ob/gyn, and urology, and its intended markets are outpatient centers and large private practices.
Both systems are semiautomatic and suitable for mobile applications.
The new SDU-450 XL includes an upgraded CPU with faster processing and enhanced applications software for ob/gyn, urology, emergency medicine, and family practice.
Shimadzu Ultrasound systems include Shimadzu's Truevision broadband probe technology with frequency versatility of 2 to 15 MHz.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.